Michael Oberst

Title: Michael Oberst: Innovator in Bispecific Binding Proteins

Introduction

Michael Oberst is a prominent inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of bispecific binding proteins. With a total of 6 patents to his name, Oberst's work has the potential to impact therapeutic approaches in various medical conditions.

Latest Patents

Oberst's latest patents focus on bispecific binding proteins and their uses. The disclosures generally provide proteins that bind two epitopes, which are bivalent for binding to each of the first and second epitopes. These specific binding proteins, including antibodies, are designed to bind to a target protein. The patents also encompass compositions comprising such proteins, nucleic acid molecules encoding these proteins, and methods for their production. Furthermore, the disclosures outline methods for inducing an immune response in a subject, as well as strategies for treating or preventing cancer by administering these proteins, nucleic acid molecules, and/or compositions.

Career Highlights

Michael Oberst is currently associated with MedImmune Limited, a leading biotechnology company. His work at MedImmune has allowed him to collaborate with other talented professionals in the field, contributing to innovative solutions in healthcare.

Collaborations

Some of his notable coworkers include Scott A Hammond and Melissa Marie Damschroder. Their collaborative efforts have further advanced the research and development of bispecific binding proteins.

Conclusion

Michael Oberst's contributions to the field of biotechnology, particularly through his patents on bispecific binding proteins, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapies.